Alvotech, Sweden and Biocimilar Candidates Hears XB003 ROO & D operations

Alvotech (Nasdaq:Target) On Thursday, the Xbrane Biopharma EU’s R & D operations and biosimilar announced the purchase of the EU operations and biocimilar candidates in the Swedish Life Science Sector.

This Purchase price of purchase 275 million ($ 27 million) is equal to the value of the SEK and will